Biography

Aman Josan is a research Optometrist at the Oxford eye hospital. His research interests include medical imaging technologies and A.I. image and data analysis. He is also interested in measures to assess treatment effectiveness.

Download my resumé.

Interests
  • Artificial Intelligence
  • Computer vision
  • Medical image/data analysis
  • Network meta-analyses
  • Clinical trial endpoints
  • Vision testing development
Education

  • PhD in Physics, 2010

    Univeristy of Nottingham

  • Part III mathematical tripos, 2006

    Cambridge university

  • BSc in Physics, 2006

    University of Manchester

  • BSc in Optometry, 2000

    Cardiff University of Wales

Skills

R
Statistics
Data analysis

Experience

 
 
 
 
 
Research Optometrist
Sep 2019 – Present Oxford Eye Hospital
Research Optometrist in clinical trials for gene therapy based treatment for inherited retinal conditions
 
 
 
 
 
Community Optometrist
Sep 2017 – Sep 2019 Robert Stanley Opticians
 
 
 
 
 
Clinical supervisor
Dec 2014 – Apr 2016 Aston University
 
 
 
 
 
Community Optometrist
Dec 2010 – Oct 2017 Specsavers Opticians

Featured Publications

Ranked importance of visual function outcome measures in choroideremia clinical trials
Microperimetry reliability should be assessed using fixation performance as summarized by BCEA95 rather than the level of fixation losses.
Code DOI
Ranked importance of visual function outcome measures in choroideremia clinical trials
Microperimetry Reliability Assessed From Fixation Performance
Microperimetry reliability should be assessed using fixation performance as summarized by BCEA95 rather than the level of fixation losses.
Code DOI
Microperimetry Reliability Assessed From Fixation Performance
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept and Laser for Retinopathy of Prematurity
Topic: To compare bevacizumab, ranibizumab, aflibercept, and laser treatment as primary therapies for retinopathy of prematurity (ROP) …
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept and Laser for Retinopathy of Prematurity
Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity
As microperimetry has become an outcome measure in several gene-therapy clinical trials, three-dimensional visualization and volumetric sensitivity enables a complementary analysis of baseline disease characteristics and subsequent response to treatment, both as a signal of safety and efficacy.
Code DOI
Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity

Recent Publications

Quickly discover relevant content by filtering publications.
Exploring Scotopic Microperimetry as an Outcome Measure in Choroideremia
Purpose: Choroideremia is an X-linked outer retinal degeneration. Early symptoms include nyctalopia and progressive visual field loss, …
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
Purpose: Cotoretigene toliparvovec (BIIB112/AAV8-RPGR) is an investigational vector-based gene therapy designed to provide a …
Establishing Clinical Trial Endpoints in Selecting Patients for RPGR Retinal Gene Therapy
Purpose: Clinical trials for X-linked retinitis pigmentosa (RP) often assess retinal structure using optical coherence tomography (OCT) …
Investigating the impact of asymmetric macular sensitivity on visual acuity chart reading in choroideremia
Introduction: Degeneration in choroideremia, unlike typical centripetal photoreceptor degenerations, is centred temporal to the fovea. …
Choroideremia: The Endpoint Endgame
Choroideremia is an X-linked retinal degeneration resulting from the progressive, centripetal loss of photoreceptors and …
See all publications

Contact

  • Amandeep.Josan@ndcn.ox.ac.uk
  • Eye Research Group Oxford, Oxford University Hospitals NHS Foundation Trust John Radcliffe Hospital, Oxford, Oxfordshire OX3 9DU